Edition:
United Kingdom

People: TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

14.05USD
18 May 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$14.05
Open
$14.10
Day's High
$14.23
Day's Low
$14.00
Volume
176,498
Avg. Vol
281,592
52-wk High
$17.30
52-wk Low
$7.25

Charney, Laurence 

Mr. Laurence Neil Charney is an Independent Director of TG Therapeutics, Inc., since March 2012. Since 2007, Mr. Charney has served as a business strategist and financial advisor to Boards, CEOs and investors. Previously, from 1970 through June 2007, Mr. Charney was a senior audit partner at Ernst & Young, LLP, a registered public accounting firm, retiring as a practice leader in the Americas Quality and Risk Management Group. Mr. Charney currently serves as an executive responsible for quality and professional leadership development for Frankel, Loughran, Starr & Vallone, LLP, CPA's and as a director and audit committee chairman of Pacific Drilling S.A. and Kenon Holdings LTD, both NYSE listed companies. In addition, Mr. Charney previously served as a director and audit committee member of Marvel Entertainment, Inc., Mrs. Fields Original Cookies, XTL Biopharmaceuticals, Ltd., Pure Biofuels, Inc., and Iconix Brand Group, Inc. In addition to his extensive experience on the boards of various corporate entities, Mr. Charney is also active on the boards of several non-profit organizations. Mr. Charney graduated with a B.B.A. degree from Hofstra University and completed the Executive MBA in Business program at Columbia University.

Basic Compensation

Total Annual Compensation, USD 60,000
Restricted Stock Award, USD 75,003
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 135,003

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Weiss

3,876,940

Sean Power

837,864

Laurence Charney

135,003

Yann Echelard

125,003

Kenneth Hoberman

125,003

Daniel Hume

--
As Of  31 Dec 2016